Haematological Diseases

Haematological Diseases

Haematological diseases are disorders affecting the blood, blood-forming organs, or components of the blood such as red blood cells (RBCs), white blood cells, platelets, and plasma proteins. These disorders may result from abnormalities in the production, structure, function, or destruction of blood cells. Anaemia is one of the most common haematological disorders and occurs when the blood has an inadequate capacity to carry oxygen, usually because of reduced haemoglobin concentration or RBC mass.

Common causes of anaemia include nutritional deficiencies, genetic abnormalities, chronic diseases, blood loss, and increased destruction of RBCs. Important haematological disorders discussed in this chapter include iron deficiency anaemia, megaloblastic anaemia, sickle cell anaemia, thalassemia, hereditary and acquired anaemias, and haemophilia.

1. Anaemia

Anaemia is a condition characterized by a reduction in haemoglobin concentration, haematocrit, or RBC mass below the normal range for the individual’s age and sex. Because haemoglobin is responsible for carrying oxygen, anaemia can reduce oxygen delivery to tissues.

Common manifestations of anaemia

The clinical features depend on the severity and rate of development of anaemia. Common symptoms include:

·         Fatigue and weakness

·         Pallor of skin and mucous membranes

·         Shortness of breath, particularly on exertion

·         Dizziness or headache

·         Palpitations

·         Reduced exercise tolerance

·         Cold hands and feet

·         Poor concentration

Severe or rapidly developing anaemia may cause tachycardia, chest discomfort, breathlessness, and tissue hypoxia.

2. Classification of Anaemia

Anaemia can be classified according to the size of RBCs (mean corpuscular volume, MCV) or according to its underlying cause.

Type

MCV

Common examples

Microcytic anaemia

<80 fL

Iron deficiency anaemia, thalassemia

Normocytic anaemia

80–100 fL

Acute blood loss, chronic disease, haemolysis

Macrocytic anaemia

>100 fL

Vitamin B12 deficiency, folate deficiency

Another useful classification is based on the mechanism:

·         Decreased RBC production

·         Increased RBC destruction (haemolysis)

·         Blood loss

3. Iron Deficiency Anaemia

Iron deficiency anaemia (IDA) is the most common nutritional deficiency anaemia worldwide. Iron is essential for the synthesis of haemoglobin, and inadequate iron availability results in reduced haemoglobin production.

The developing RBCs become progressively smaller and contain less haemoglobin, producing a microcytic, hypochromic anaemia.

Causes

Iron deficiency may occur because of:

·         Inadequate dietary iron intake

·         Increased iron requirements during growth

·         Pregnancy

·         Chronic blood loss

·         Menstrual blood loss

·         Gastrointestinal bleeding

·         Malabsorption

·         Repeated blood donation

Pathophysiology

The development of iron deficiency can be understood as a progressive process:

Reduced iron intake/absorption or increased iron loss
↓
Depletion of iron stores
↓
Reduced serum iron availability
↓
Reduced haemoglobin synthesis
↓
Small, pale RBCs
↓
Reduced oxygen-carrying capacity
↓
Symptoms of anaemia

Initially, body iron stores decrease without obvious anaemia. As deficiency progresses, haemoglobin synthesis becomes impaired and microcytic, hypochromic RBCs develop.

Clinical features

In addition to general features of anaemia, patients may develop:

·         Brittle nails

·         Hair loss

·         Glossitis

·         Angular cheilitis

·         Pica

·         Reduced concentration and work capacity

Laboratory findings

Typical findings include:

·         Low haemoglobin

·         Low MCV

·         Low MCH

·         Low serum ferritin

·         Low serum iron

·         Increased total iron-binding capacity (TIBC)

·         Increased transferrin

·         Increased red cell distribution width (RDW)

Serum ferritin generally reflects body iron stores, although ferritin may increase during inflammation because it is also an acute-phase protein.

4. Megaloblastic Anaemia

Megaloblastic anaemia results from impaired DNA synthesis, leading to abnormal maturation of developing RBC precursors in the bone marrow. The major nutritional causes are vitamin B12 deficiency and folate deficiency.

The impaired DNA synthesis produces large, immature precursor cells called megaloblasts. Circulating RBCs are typically large, producing macrocytic anaemia.

Basic mechanism

Vitamin B12/Folate deficiency
↓
Impaired DNA synthesis
↓
Delayed nuclear maturation
↓
Abnormal megaloblastic maturation
↓
Macrocytic anaemia

5. Vitamin B12 Deficiency Anaemia

Vitamin B12 is required for normal DNA synthesis and neurological function. It is obtained primarily from animal-derived foods and is absorbed in the terminal ileum after binding to intrinsic factor, which is produced by gastric parietal cells.

Causes of vitamin B12 deficiency

·         Poor dietary intake, particularly in strict vegans without supplementation

·         Pernicious anaemia

·         Gastric surgery or severe gastric disease

·         Ileal disease or resection

·         Malabsorption

·         Certain medications

·         Prolonged nutritional deficiency

Pathophysiology

Vitamin B12 deficiency causes defective DNA synthesis in rapidly dividing cells, particularly bone marrow cells. This results in ineffective erythropoiesis and the formation of large abnormal RBC precursors.

Vitamin B12 deficiency also interferes with normal neurological metabolism. Therefore, neurological manifestations may occur in addition to anaemia.

Clinical features

·         Fatigue

·         Pallor

·         Weakness

·         Glossitis

·         Loss of appetite

·         Weight loss

·         Numbness or tingling

·         Difficulty walking or balance problems

·         Cognitive or neurological changes in severe or prolonged deficiency

Neurological manifestations are an important distinguishing feature of vitamin B12 deficiency.

Laboratory findings

·         Increased MCV

·         Reduced haemoglobin

·         Macro-ovalocytes

·         Hypersegmented neutrophils

·         Reduced serum vitamin B12

·         Increased methylmalonic acid

·         Increased homocysteine

6. Folate Deficiency Anaemia

Folate (vitamin B9) is essential for DNA synthesis and normal cell division. Folate deficiency produces megaloblastic anaemia similar to vitamin B12 deficiency but does not typically cause the characteristic neurological injury associated with vitamin B12 deficiency.

Causes

·         Poor dietary intake

·         Increased requirement during pregnancy

·         Malabsorption

·         Alcohol use disorder

·         Certain medications that interfere with folate metabolism

·         Chronic illnesses associated with poor nutrition

Clinical features

·         Fatigue

·         Pallor

·         Weakness

·         Shortness of breath

·         Glossitis

·         Gastrointestinal symptoms

Laboratory findings

·         Macrocytic anaemia

·         Macro-ovalocytes

·         Hypersegmented neutrophils

·         Reduced serum or red-cell folate

·         Increased homocysteine

·         Normal methylmalonic acid

 


Table 1: Vitamin B12 Deficiency vs Folate Deficiency

Feature

Vitamin B12 deficiency

Folate deficiency

Anaemia

Megaloblastic

Megaloblastic

RBC size

Increased MCV

Increased MCV

DNA synthesis

Impaired

Impaired

Homocysteine

Increased

Increased

Methylmalonic acid

Increased

Normal

Neurological manifestations

May occur

Absent

Important dietary sources

Animal-derived foods

Green leafy vegetables, legumes, fortified foods


Clinical point: Folate supplementation can improve the anaemia of vitamin B12 deficiency while allowing neurological damage to progress. Therefore, vitamin B12 deficiency should be appropriately excluded before treating unexplained megaloblastic anaemia with folate alone.

7. Sickle Cell Anaemia

Sickle cell anaemia is an inherited haemoglobin disorder caused by a mutation in the β-globin gene, resulting in production of abnormal haemoglobin known as haemoglobin S (HbS).

When oxygen levels are low, HbS can polymerize, causing RBCs to become rigid and adopt a characteristic sickle or crescent shape.

Pathophysiology

HbS formation
↓
Deoxygenation
↓
HbS polymerization
↓
RBC sickling and rigidity
↓
Vaso-occlusion + haemolysis
↓
Tissue ischemia + chronic anaemia

Sickled RBCs have reduced flexibility and may obstruct small blood vessels. They are also more susceptible to premature destruction, producing chronic haemolytic anaemia.

Clinical features

·         Chronic anaemia

·         Fatigue and pallor

·         Recurrent painful vaso-occlusive episodes

·         Increased susceptibility to certain infections

·         Jaundice due to haemolysis

·         Acute chest syndrome

·         Splenic dysfunction

·         Stroke and other organ complications

Factors that may precipitate sickling

·         Dehydration

·         Hypoxia

·         Infection

·         Extreme physical stress

·         Acidosis

·         Cold exposure

Diagnosis

Diagnosis may involve:

·         Complete blood count

·         Peripheral blood smear

·         Haemoglobin analysis

·         Haemoglobin electrophoresis or equivalent laboratory methods

·         Genetic testing when appropriate

8. Thalassemia

Thalassemia comprises inherited disorders characterized by reduced synthesis of one or more globin chains of haemoglobin. The two major forms are α-thalassemia and β-thalassemia.

Reduced globin production results in defective haemoglobin synthesis and ineffective erythropoiesis. Increased destruction of abnormal RBCs also contributes to anaemia.

Pathophysiology

Reduced globin-chain synthesis
↓
Reduced normal haemoglobin formation
↓
Ineffective erythropoiesis + haemolysis
↓
Chronic anaemia
↓
Increased erythropoietic drive and compensatory changes

Clinical features

Severity varies greatly depending on the type and genotype.

·         Pallor

·         Fatigue

·         Jaundice

·         Splenomegaly

·         Growth retardation in severe childhood disease

·         Bone changes due to increased marrow activity

·         Iron overload in patients receiving repeated transfusions

Major forms

Type

General characteristic

α-thalassemia

Reduced α-globin production

β-thalassemia

Reduced β-globin production

Thalassemia trait

Usually mild or asymptomatic anaemia

Severe thalassemia

May require regular transfusion and specialized care

Important distinction from iron deficiency

Both iron deficiency and thalassemia can produce microcytic anaemia, but iron studies and haemoglobin analysis help distinguish them. Iron supplementation should not be given routinely to a person with thalassemia unless iron deficiency has been demonstrated.

9. Hereditary Anaemias

Hereditary anaemias are anaemias caused by inherited genetic abnormalities affecting haemoglobin, RBC membrane proteins, or enzymes required for RBC survival.

 Important examples include:

·         Sickle cell anaemia

·         Thalassemia

·         Hereditary spherocytosis

·         Glucose-6-phosphate dehydrogenase (G6PD) deficiency

·         Other inherited RBC enzyme or membrane disorders

General mechanism

Genetic defect
↓
Abnormal haemoglobin, membrane, or RBC enzyme
↓
Reduced RBC survival and/or abnormal RBC structure
↓
Anaemia

Some hereditary anaemias are predominantly haemolytic, while others result mainly from ineffective RBC production.

10. Acquired Anaemias

Acquired anaemias develop during a person’s lifetime and are not directly caused by an inherited genetic abnormality.

Common causes include:

·         Iron deficiency

·         Vitamin B12 or folate deficiency

·         Chronic kidney disease

·         Chronic inflammatory diseases

·         Acute or chronic blood loss

·         Autoimmune haemolysis

·         Drug-induced haemolysis

·         Bone marrow disorders

·         Endocrine and systemic diseases

General mechanisms

Acquired anaemia may develop through:

Reduced RBC production
or
Increased RBC destruction
or
Blood loss

 


Table 2: Hereditary and Acquired Anaemia: Comparison

Feature

Hereditary anaemia

Acquired anaemia

Basic cause

Genetic abnormality

Develops after birth due to various causes

Examples

Sickle cell disease, thalassemia, hereditary spherocytosis

Iron deficiency, B12 deficiency, chronic disease

Onset

Often early, but variable

Variable

Family history

May be present

Absent

Treatment

Depends on specific genetic disorder

Treat underlying cause

Prevention

Genetic counselling and screening may help

Often depends on prevention of underlying cause


11. Haemophilia

Haemophilia is an inherited bleeding disorder caused by deficiency or dysfunction of specific coagulation factors. The two major forms are haemophilia A and haemophilia B.

·         Haemophilia A: Factor VIII deficiency

·         Haemophilia B: Factor IX deficiency

Both affect the intrinsic pathway of coagulation and result in impaired thrombin generation and fibrin clot formation.

Pathophysiology

Factor VIII or IX deficiency
↓
Impaired intrinsic activity
↓
Reduced Factor X activation
↓
Reduced thrombin generation
↓
Reduced fibrin formation
↓
Impaired stable clot formation
↓
Prolonged bleeding

Clinical features

Haemophilia commonly produces deep tissue and joint bleeding, rather than only superficial bleeding.

Important manifestations include:

·         Prolonged bleeding after injury or procedures

·         Recurrent joint bleeding (haemarthrosis)

·         Muscle haematomas

·         Easy bruising

·         Deep tissue bleeding

·         Intracranial bleeding in severe cases

Repeated bleeding into joints can cause chronic joint damage.

Laboratory findings

Typical findings include:

·         Prolonged activated partial thromboplastin time (aPTT)

·         Usually normal prothrombin time (PT)

·         Platelet count generally normal

·         Reduced activity of the affected clotting factor

Inheritance

Classical haemophilia A and B are usually X-linked recessive disorders and therefore occur predominantly in males, while females may be carriers or, less commonly, affected under specific genetic circumstances.

Treatment

Management depends on disease severity and clinical circumstances and may include:

·         Replacement of the deficient clotting factor

·         Recombinant factor concentrates

·         Desmopressin (DDAVP) in selected patients with mild haemophilia A

·         Antifibrinolytic agents for selected mucosal bleeding

·         Non-factor therapies such as emicizumab for appropriate patients with haemophilia A


Table 3: Comparison of Major Haematological Disorders

Disorder

Primary defect

Main type

Characteristic feature

Iron deficiency anaemia

Iron deficiency

Microcytic

Reduced haemoglobin synthesis

Vitamin B12 deficiency

B12 deficiency

Macrocytic/megaloblastic

Neurological manifestations may occur

Folate deficiency

Folate deficiency

Macrocytic/megaloblastic

No typical neurological involvement

Sickle cell anaemia

HbS production

Haemolytic

Sickling and vaso-occlusion

Thalassemia

Reduced globin synthesis

Microcytic/haemolytic

Ineffective erythropoiesis

Hereditary spherocytosis

RBC membrane defect

Haemolytic

Spherocytes and haemolysis

G6PD deficiency

RBC enzyme deficiency

Haemolytic

Episodic haemolysis after oxidative stress

Haemophilia A

Factor VIII deficiency

Bleeding disorder

Deep bleeding and haemarthrosis

Haemophilia B

Factor IX deficiency

Bleeding disorder

Deep bleeding and haemarthrosis


12. Key Laboratory Investigations

Laboratory investigations help identify the type and cause of a haematological disorder.

Common investigations

·         Complete blood count (CBC): Measures haemoglobin, RBC indices, WBC count, and platelet count.

·         Peripheral blood smear: Provides information about RBC size, shape, colour, and abnormal cells.

·         Reticulocyte count: Helps assess bone marrow response to anaemia.

·         Serum ferritin and iron studies: Useful in evaluating iron status.

·         Vitamin B12 and folate levels: Help investigate macrocytic anaemia.

·         Haemoglobin analysis: Important in suspected sickle cell disease and thalassemia.

·         Coagulation tests: PT/INR and aPTT help evaluate clotting disorders.

·         Specific factor assays: Used to identify coagulation factor deficiencies such as haemophilia.


Table 4: High-Yield Clinical Comparison

Feature

Iron Deficiency

B12/Folate Deficiency

Sickle Cell Anaemia

Thalassemia

RBC size

Small

Large

Normocytic

Small

Main defect

Iron deficiency

Impaired DNA synthesis

Abnormal HbS

Reduced globin synthesis

Haemolysis

Absent

Ineffective erythropoiesis

Prominent

Variable/prominent

Neurological signs

No

B12: Yes

Not characteristic

Not characteristic

Genetic

No

Usually acquired

Yes

Yes

Major complication

Tissue hypoxia

Neurological damage in B12 deficiency

Vaso-occlusion

Iron overload in transfusion-dependent disease


 

Leave a Comment

Your email address will not be published. Required fields are marked *